1. Introduction {#sec1}
===============

Epilepsy is the second most troublesome neurologic disorder worldwide in terms of disability-adjusted life years \[[@B1]\]. Epilepsy is a global public health problem that affects more than 70 million people worldwide \[[@B2]\], and more than 85% of the global burden of epilepsy occurs in developing countries \[[@B3], [@B4]\]. In Africa, epilepsy affected about 10 million people \[[@B5]\]. Ethiopia is also one of the highly affected countries in Africa with an estimated prevalence of 5.2/1000 population \[[@B6]\]. Epilepsy is a debilitating illness that leads to neuropsychological impairment, impairment of quality of life, frequent physical injury, social stigma, poor academic performance, reduced employment rate, and shortened lifetime \[[@B6]--[@B8]\].

Despite the availability of effective medications, there is a huge gap in the treatment of epilepsy in developing countries, particularly in Africa owing to the poor healthcare system, illiteracy, poor health awareness, and cultural unacceptance of modern medicine \[[@B4], [@B9]--[@B12]\]. In developing countries, epilepsy-associated stigma leads to higher treatment gaps, poor treatment outcomes, and reduced quality of life in epileptic patients \[[@B13]\]. In Africa, the majority of people still believe that epilepsy is caused by an evil spirit that cannot be effectively treated with modern medicine \[[@B5]\]. Antiepileptic drugs (AEDs) are the mainstay of therapy in the management of epilepsy and can achieve seizure freedom in 70% of patients if effective regimen is followed \[[@B14]\]. However, epilepsy remains uncontrolled in the majority of patients with epilepsy in developing countries \[[@B15]\]. Nonadherence remains the leading cause of treatment failure in epilepsy \[[@B16], [@B17]\].

Medication adherence is the extent to which patients take their medications as prescribed with respect to dosage and dosage intervals throughout the treatment period \[[@B18]\]. Despite medication adherence is a crucial part of patient care to achieve the desired goal of treatment, more than half of the patients are nonadherent to their prescribed medicines \[[@B19], [@B20]\]. Studies have reported that the rate of adherence to AEDs ranges from 32 to 62% \[[@B16], [@B21]--[@B23]\]. Many factors including belief about medications, comorbidity, number of medications, duration of therapy, age, gender, and educational status have been associated with the rate of medication adherence \[[@B22], [@B23]\]. Medication belief is the most important predictor of medication adherence, and it was significantly associated with medication adherence in different studies \[[@B24], [@B25]\]. Nonadherence to AED leads to poor seizure control, frequent hospital admissions, increased healthcare cost, impaired quality of life, and increased risk of mortality \[[@B17], [@B26], [@B27]\].

Assessment of medication adherence and belief and identification of factors affecting adherence to ADEs is important to improving overall epilepsy treatment outcome. However, there is a lack of study on medication adherence and belief and associated factors in our setting. Therefore, the aim of the current study was to (i) assess medication adherence and belief and (ii) evaluate the association of medication belief and other factors with medication adherence in patients with epilepsy.

2. Material and Methods {#sec2}
=======================

2.1. Study Design and Study Setting {#sec2.1}
-----------------------------------

A cross-sectional study was conducted between January 2017 and April 2017 at the neurologic clinic of Ayder Comprehensive Specialized Hospital which is located in northern Ethiopia. It is the second largest public hospital in Ethiopia that provides service for about 10 million people.

### 2.1.1. Study Population and Data Collection Procedure {#sec2.1.1}

Adult epileptic patients (age ≥ 18 years), patients who were taking at least one AED, and those who had been on follow-up for at least six months were included in the study. Patients who were too ill to complete the interview, those who refused to give consent, and those with incomplete medical records were excluded from the study.

A sample of 304 was calculated using a single population proportion formula assuming 50% rate of medication adherence among patients with epilepsy, 95% confidence level, 5% margin of error, and 10% of contingency for nonresponse rate. From a total of 304 subjects approached, 12 patients were excluded from the study due to unwillingness to give consent \[[@B5]\], incomplete medical record \[[@B4]\], and serious illness to complete the interview \[[@B3]\].

We recruited patients into the study during their appointment for medication refilling using simple random sampling technique. Information related to sociodemographics, medication adherence, and belief was retrieved by interviewing patients using the standardized questionnaire. The clinical and treatment-related characteristics were retrieved from patients\' medical record using the data abstraction checklist.

The Belief about Medicines Questionnaire (BMQ) was used to assess patients\' belief about their medication \[[@B28]\]. BMQ is a self-reported questionnaire that encompasses two five-item scales evaluating the patients\' belief about the necessity of their medications for controlling their disease and their concerns about the potential adverse effects of taking medications. According to BMQ, participants were said to have high medication necessity belief if the average sum of the five-item medication necessity scale score (ranging from 5-25) is above the midpoint; otherwise, they were considered to have low medication necessity belief. Similarly, participants were said to have high concern belief if the average sum of the five-item medication concern scale score (ranging from 5-25) is above the midpoint; otherwise, they were considered to have low medication concern belief. The overall patients\' belief about their medication was determined by necessity concern differential, in which the patient\'s belief was considered as positive when the average sum of the 5-item patient\'s medication necessity scale score exceeded the average 5-item medication concerns scale; otherwise, it was considered as negative \[[@B29]\].

Medication adherence was assessed using a self-reported questionnaire which was developed based on the review of different literatures \[[@B17], [@B20], [@B30], [@B31]\]. Patients were asked whether or not they missed or stopped a dose of their AED for any reason in the last month. We assessed adherence level in the last one-month period because of published literatures supporting the one-month recall period \[[@B17], [@B32], [@B33]\]. Accordingly, patients who took their AEDs appropriately according to the prescriber\'s instruction without missing or stopping a dose in the last month were said to be adherent, whereas patients who missed or stopped a dose of their AEDs within the last month were considered as nonadherent.

### 2.1.2. Data Analysis {#sec2.1.2}

Data were analyzed using the Statistical Package for the Social Sciences (SPSS version 21.0). We checked multicollinearity to test the correlation among predictor variables using the variance inflation factor (VIF), and none was collinear. Univariable logistic regression analysis was performed to determine the association of each independent variable with medication adherence, and a further multivariable binary logistic regression model was done to identify predictors of medication adherence. A *p* value of \<0.05 was considered statistically significant in all analyses.

### 2.1.3. Ethical Approval {#sec2.1.3}

This study was approved by the Ethics Review Committee of the School of Pharmacy, College of Health Sciences, Mekelle University. All study participants were well informed about the objective and protocol of the study. Written informed consent was obtained from all participants. Additionally, the privacy of personal information was strictly preserved. All the methods were performed in accordance with approved institutional guidelines.

3. Result {#sec3}
=========

3.1. Sociodemographic Characteristics {#sec3.1}
-------------------------------------

We included 292 patients in the final analysis of the study. Out of the total, 179 (61.3%) were males and the mean (± SD) age was 30.46 ± 10.82 years. More than half, 156 (53.4), were rural dwellers, and 14.4% were social drug users ([Table 1](#tab1){ref-type="table"}).

3.2. Clinical and Treatment-Related Characteristics {#sec3.2}
---------------------------------------------------

Three-fourths (75.7%) of the participants had generalized epilepsy while 14.4% had focal epilepsy. Generalized tonic-clonic seizure (73.6%) was the most common type of seizure, and 39% of the patients had one or more comorbidities. Nearly two-thirds (61%) of the patients had been on treatment for five or more years, and 45.5% of the patients encountered seizure within the last 3 months. The most commonly prescribed AED was phenobarbitone (54.8%) followed by phenytoin (52.1%) ([Table 2](#tab2){ref-type="table"}).

3.3. Medication Belief of the Participants {#sec3.3}
------------------------------------------

More than three-fourths (78.4%) of the patients had high necessity belief about the importance of their medication for controlling their illness while 44.1% had high concern belief about the potential adverse effect of their medications. Overall, 60.6% had a positive perception toward their AEDs ([Table 3](#tab3){ref-type="table"}).

In our study, two-thirds (65.4%) of the patients were nonadherent to their AEDs. The most common cause for nonadherence was forgetfulness (48.7%) followed by inability to get medicine (28.8), safety concern (23.5%), and affordability problem (21.5%) ([Table 4](#tab4){ref-type="table"}).

3.4. Factors Associated with Medication Adherence {#sec3.4}
-------------------------------------------------

Univariable logistic regression analysis was performed to compare adherent and nonadherent epileptic patients using the sociodemographic, medication belief, clinical, and treatment related characteristics. Accordingly, social drug use \[crude odds ratio (COR): 2.21, 95% CI: 1.02-4.82\], comorbidity \[COR: 5.60, 95% CI: 3.06-10.25\], number of medications ≥ 3 \[COR: 2.21, 95% CI: 1.35-3.61\], seizure encounter within the last 3 months \[COR: 11.44, 95% CI: 5.96-21.96\], low medication necessity belief \[COR: 6.74, 95% CI: 2.8-16.26\], high medication concern belief \[COR: 7.00, 95%: 3.86-12.71\], and negative medication belief \[COR: 9.78, 95% CI: 4.92-19.46\] were significantly associated with medication adherence ([Table 5](#tab5){ref-type="table"}).

Variables with *p* \< 0.2 in the univariable analyses were included in the multivariable logistic regression model. The full model containing all predictors was statistically significant (chi-square = 137.207, df = 12, *P* \< 0.001). Comorbidity (AOR: 3.51, 95% CI: 1.20-10.31), seizure encounter within the last 3 months (AOR: 5.45, 95% CI: 2.48-12.00), low medication necessity belief (AOR: 3.38, 95% CI: 1.14-10.00), high medication concern belief (AOR: 4.23, 95% CI: 2.07-8.63), and negative medication belief (AOR: 4.17, 95% CI: 1.74-10.02) were found to be predictors of medication nonadherence ([Table 5](#tab5){ref-type="table"}).

4. Discussion {#sec4}
=============

Adherence to antiepileptic drugs is crucial to improving seizure control and overall treatment outcome in epileptic patients. However, maintaining good adherence to antiepileptic drugs remained the most important challenge in the globe, particularly in developing countries \[[@B18], [@B34]\]. Assessment of medication adherence and its contributing factors is helpful to designing programs for future intervention. Therefore, our study investigated the rate of nonadherence and its contributing factors among epileptic patients.

Studies have shown that most of the patients with epilepsy in developing countries are not treated or not appropriately treated \[[@B11], [@B35], [@B36]\]. In line with other similar studies \[[@B22], [@B23], [@B37], [@B38]\], majority (65.4%) of the patients were nonadherent to their AED in our study. In contrast, the rate of adherence in our study was lower than those in studies done in China \[[@B39]\] and Germany \[[@B40]\]. The reason for this variance could be the poor perception of patients toward their illnesses and medication in developing countries including Ethiopia. In addition, it could be attributed to the difference in methods of adherence assessment.

Forgetfulness was the major reason for nonadherence in our study which is also supported by other similar studies \[[@B22], [@B38], [@B41]\]. Next to forgetfulness, the inability to obtain medication and safety concern were common causes of nonadherence. A similar finding was also reported in another similar study \[[@B21]\].

In our study, majority of patients had a positive belief about their medication which is comparable with a Saudi Arabian study \[[@B21]\]. Our study reported that majority of the patients had a high medication necessity belief about their AEDs while over one-third of the patients had high concern belief about the potential adverse effects of their medications which is similar with a United Kingdom study \[[@B25]\].

Medication belief was found to be an important predictor of medication adherence across different studies \[[@B24], [@B42]\]. Consistent with these studies, belief about medication was significantly associated with the rate of medication adherence in our study. In agreement to other studies \[[@B21], [@B25], [@B38], [@B43]\], patients with low necessity belief, high concern belief, and negative medication belief toward their AEDs were more likely to be nonadherent to their medications in this study. Therefore, more effort needs to be done to improve the awareness of patients about the importance of their medication in order to improve medication adherence.

In the present study, epileptic patients with comorbidity were less likely to be adherent to their medications which is also augmented by another similar study \[[@B22]\]. This could be explained that patients with comorbidity are more likely to have multiple drugs. Thus, they could be reluctant to take all drugs properly. Moreover, the risk of adverse drug events is increased in patients with comorbidities which can also negatively affect the adherence rate.

Several studies revealed that nonadherence to AEDs was significantly associated with poor seizure control \[[@B16], [@B17], [@B44]\]. Likewise, patients with uncontrolled seizure were more likely to be nonadherent to their AEDs in the present study. This finding suggests that healthcare providers should design educational programs to enhance medication adherence so as to improve epilepsy treatment outcome.

Our study has some limitations. Our study may not provide adequate evidence regarding the cause-effect relationship of medication adherence and its risk factors due to the inherent characteristics of the cross-sectional study. In addition, as medication adherence and belief were assessed using self-reported data, patients may have underestimated these undesirable activities due to self-report concerns.

5. Conclusion {#sec5}
=============

Majority of the epileptic patients were nonadherent to their medications, and forgetfulness was the common cause of nonadherence in this study. More than one-third of the patients had a negative belief about their medications. Low medication necessity belief, high medication concern belief, negative medication belief, comorbidity, and seizure encounter within the last 3 months were significantly associated with medication nonadherence. Therefore, healthcare providers should design educational programs to enhance the patients\' belief about their medication in order to improve medication adherence and overall treatment outcome. Moreover, more emphasis should be given to patients with comorbidity and poor seizure control.
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###### 

Sociodemographic characteristics of epileptic patients (*n* = 292).

  Characteristics             *n* (%)
  --------------------------- ------------
  Gender                      
   Male                       179 (61.3)
   Female                     113 (38.7)
  Age in years                
   18-30                      172 (58.9)
   31-60                      112 (38.4)
   \>60                       8 (2.7)
  Marital status              
   Married                    81 (27.7)
   Single                     172 (58.9)
   Divorce                    24 (8.2)
   Widowed                    15 (5.1)
  Residence                   
   Rural                      156 (53.4)
   Urban                      136 (46.6)
  Educational level           
   Unable to write and read   50 (17.1)
   Primary school             100 (34.2)
   Secondary school           124 (42.5)
   Tertiary school            18 (6.2)
  Employment status           
   Employed                   27 (27.9)
   Unemployed                 207 (70.9)
  Social drug use             
   No                         250 (85.6)
   Yes                        42 (14.4)
  Monthly income              315 (92.7)
   ≤1500                      152 (52.1)
   \>1500                     140 (47.9)

###### 

Clinical and treatment-related characteristics of epileptic patients (*n* = 292).

  Characteristics                              *n* (%)
  -------------------------------------------- ------------
  Comorbidity                                  
   No                                          178 (61.0)
   Yes                                         114 (39)
  Major comorbidities                          
   Psychiatric disorder                        49 (16.8)
   Migraine headache                           25 (8.5)
   Cardiovascular disorder                     24 (8.2)
   Respiratory disorders                       16 (5.5)
  Type of epilepsy                             
   Generalized epilepsy                        221 (75.7)
   Focal epilepsy                              42 (14.4)
   Unknown                                     29 (9.9)
  Type of seizure                              
   GTC                                         215 (73.6)
   Focal seizure                               42 (14.4)
   Absence seizure                             6 (2.1)
   Unclassified seizure                        29 (9.9)
  Duration of treatment                        
   \<5                                         114 (39)
   ≥5                                          178 (61)
  Commonly used medications                    
   Phenobarbitone                              160 (54.8)
   Phenytoin                                   152 (52.1)
   Carbamazepine                               90 (30.8)
   Valproate                                   89 (30.5)
  Seizure encounter in the last three months   
   No                                          159 (54.5)
   Yes                                         133 (45.5)
  Number of medicines per patient              
   \<3 medication                              142 (48.6)
   ≥3 medication                               150 (51.4)

###### 

Medication belief of the participants (*n* = 292).

  Variables                         *n* (%)
  --------------------------------- ------------
  Overall belief about medication   
   Negative belief                  115 (39.4)
   Positive belief                  177 (60.6)
  Medication necessity belief       
   High necessity belief            229 (78.4)
   Low necessity belief             63 (21.6)
  Medication concern belief         
   High concern belief              129 (44.2)
   Low concern belief               163 (55.8)

###### 

Adherence to AEDs and reasons for nonadherence (*n* = 292).

  Characteristics                              Number (%)
  -------------------------------------------- ------------
  Medication adherence                         
   Adherent                                    101 (34.6)
   Nonadherent                                 191 (65.4)
  Reasons for nonadherence                     
   Forgetfulness                               93 (48.7)
   Inability to get medicine                   49 (25.7)
   Safety concern                              49 (25.7)
   Cost                                        41 (21.5)
   Ran out of pills                            23 (12)
   Lack of hope                                16 (8.4)
   Not taking the medication during recovery   16 (8.4)

###### 

Factors associated with medication adherence among epileptic patients (*n* = 292).

  Predictors                    Medication adherence   COR (95% CI)   *p* value            AOR (95% CI)   *p* value           
  ----------------------------- ---------------------- -------------- -------------------- -------------- ------------------- ---------
  Age in years                                                                                                                
   18-30                        60 (59.4)              112 (58.6)     1                    1              1                   1
   31-60                        36 (35.6)              76 (39.8)      0.99 (0.60-1.64)     0.971          1.83 (0.91-3.69)    0.090
   \>60                         5 (5.0)                3 (1.6)        0.305 (0.07-1.32)    0.113          0.62 (0.07-5.55)    0.671
  Social drug use                                                                                                             
   No                           92 (91.1)              157 (82.2)     1                    1              1                   1
   Yes                          9 (8.9)                34 (17.8)      2.21 (1.02-4.82)     0.045          0.79 (0.26-2.40)    0.672
  Comorbidity                                                                                                                 
   No                           85 (84.2)              93 (48.7)      1                    1              1                   1
   Yes                          16 (15.8)              98 (51.3)      5.60 (3.06-10.25)    \<0.001        3.51 (1.20-10.31)   0.022
  Types of seizure                                                                                                            
   GTC                          72 (71.3)              143 (74.9)     1                    1              1                   1
   Focal seizure                14 (13.9)              28 (14.7)      1.85 (0.85-4.05)     0.122          0.43 (0.16-1.16)    0.096
   Absence seizure              1 (1.0)                5 (2.6)        1.87 (0.71-4.93)     0.208          0.72 (0.04-13.54)   0.823
   Unclassified seizure         14 (13.9)              28 (14.7)      4.67 (0.48-45.04)    0.183          0.57 (0.21-1.55)    0.272
  Number of medications                                                                                                       
   \<3                          62 (61.4)              80 (41.9)      1                    1              1                   1
   ≥3                           39 (38.6)              111 (58.1)     2.21 (1.35-3.61)     0.002          0.53 (0.21-1.36)    0.185
  Seizure encounter                                                                                                           
   No                           88 (87.1)              71 (37.2)                                                              
   Yes                          13 (12.9)              120 (62.8)     11.44 (5.96-21.96)   \<0.001        5.45 (2.48-12.00)   \<0.001
  Medication necessity belief                                                                                                 
   High necessity               91 (90.1)              138 (72.3)     1                    1              1                   1
   Low necessity                10 (9.9)               53 (27.7)      6.74 (2.80-16.26)    \<0.001        3.38 (1.14-10.00)   0.028
  Medication concern belief                                                                                                   
   Strong concern               17 (16.8)              112 (58.6)     7.00 (3.86-12.71)    \<0.001        4.23 (2.07-8.63)    \<0.001
   Low concern                  84 (83.2)              79 (41.4)      1                    1              1                   1
  Over all medication belief                                                                                                  
   Negative belief              11 (10.9)              104 (54.5)     9.78 (4.92-19.46)    \<0.001        4.17 (1.74-10.02)   0.001
   Positive belief              90 (89.1)              87 (45.5)      1                    1              1                   1

COR: crude odds ratio; AOD: adjusted odds ratio; CI: confidence interval; GTC: generalized tonic seizure.
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